Researchers Develop Rapid Lab-on-a-Chip for Cancer, COVID Diagnostics

A research center based at the University of Kansas that develops rapid next-generation tests for a host of human ailments like cancer, stroke, and COVID-19 recently earned $6.6 million in continued funding over the next five years from the National Institutes of Health’s National Institute of Biomedical Imaging and Bioengineering (NIBIB) as a National Biotechnology Resource (P41) Center.